Former United States Securities and Exchange Commission attorney Willie
Briscoe and the securities litigation firm of Powers
Taylor LLP are investigating potential claims against the Board of
Directors of Colonial Financial Service, Inc. (“Colonial Financial”)
(NasdaqGM: COBK) concerning the acquisition by Cape Bancorp, Inc. Under
the terms of the agreement, valued at approximately $55 million,
Colonial Financial shareholders will only receive $14.50 in cash per
share or 1.412 share of Cape Bancorp’s common stock, subject to 50% of
the shares being exchanged for stock and 50% for cash.
IT Professionals Report a Lack of High Confidence in Preventing Cyber Attacks, According to Protiviti's 2014 IT Security and Privacy Survey Companies still need to get their data security houses in order Canada NewsWire
MENLO PARK, Calif.
Sourcing industry's premier event takes place September 29-30 in Dallas Impact of disruptive technologies on service delivery and emerging opportunities and challenges to be highlighted
Sign-up for 2014/9/15 - Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action against CommVault Systems, Inc. and Lead Plaintiff Deadline of November 11, 2014 investment picks
GameStop (NYSE: GME), a family of specialty retail brands that makes
consumers favorite technologies affordable and simple, announced today
its intent to exit the Spanish market via the sale of certain retail
locations to specialist video games retailer, GAME Digital Plc (“GAME”)
in combination with closures of the remaining locations.
Global data center services provider CyrusOne (NASDAQ:CONE) announces
the availability of a complimentary case study featuring its data center
solution for the Brink’s Company, the world’s leading provider of
armored transportation services.
LibreOffice Makes Strides in Software Quality with Coverity Scan Canada NewsWire
Open office suite leverages software-scanning service to find and fix more than 10,000 defects in fewer than two years MOUNTAIN VIEW, Calif.
Baxter International Inc. (NYSE:BAX) today announced that the United
States Food and Drug Administration (FDA) has approved RIXUBIS
[Coagulation Factor IX (Recombinant)] for routine prophylactic
treatment, control and prevention of bleeding episodes, and
perioperative management in children with hemophilia B.
- Significantly Improved Agitation in 220-Patient 10-week Study - - Company Plans to Meet with FDA to Discuss Initiation of Pivotal Development Program -
- Data to be Presented at the American Neurological Association Meeting in October - ALISO VIEJO, Calif.
Biogen Idec Inc. (BIIB) of Weston, Mass., saw its second-quarter sales per share jump 42%. The big sales gain came from the Tysabri medication for multiple sclerosis and Crohn's disease, and Tecfidera, another multiple sclerosis medication.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.